Compounds > cd 3 color developer
Page last updated: 2024-12-06

cd 3 color developer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

CD 3 color developer: used in film laboratories; causes contact dermatitis & lichenoid reactions; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID66693
CHEMBL ID580441
SCHEMBL ID2157605
MeSH IDM0122329

Synonyms (42)

Synonym
AKOS005431280
92-09-1
4-amino-n-ethyl-n-(.beta.-methylsulfonamidoethyl)-m-toluidinephosphate
methanesulfonamide, n-[2-[(4-amino-3-methylphenyl)ethylamino]ethyl]-
methanesulfonamide, n-[2-(4-amino-n-ethyl-m-toluidino)ethyl]-
n-[2-(4-amino-n-ethyl-m-toluidino)ethyl]methanesulfonamide
4-amino-n-ethyl-m-(.beta.-methanesulfonamidoethyl)-m-toluidine
m-toluidine, 4-amino-n-ethyl-n-(.beta.-methanesulfonamidethyl)-
nsc517164
nsc-517164
m-toluidine, 4-amino-n-ethyl-n-(beta-methanesulfonamidethyl)-
nsc 517164
methanesulfonamide, n-(2-(4-amino-n-ethyl-m-toluidino)ethyl)-
m-toluidine, 4-amino-n-ethyl-n-(beta-methanesulfonamidoethyl)-
n-(2-((4-amino-m-tolyl)ethylamino)ethyl)methanesulphonamide
methanesulfonamide, n-(2-((4-amino-3-methylphenyl)ethylamino)ethyl)-
cd 3 color developer
n-(2-(4-amino-n-ethyl-m-toluidino)ethyl)methanesulfonamide
4-amino-n-ethyl-m-(beta-methanesulfonamidoethyl)-m-toluidine
einecs 202-124-2
4-amino-n-ethyl-n-(beta-methanesulfonamidoethyl)-m-toluidine
STK396654
n-{2-[(4-amino-3-methylphenyl)(ethyl)amino]ethyl}methanesulfonamide
n-[2-(4-amino-n-ethyl-3-methylanilino)ethyl]methanesulfonamide
unii-6vov6v71vo
6vov6v71vo ,
SCHEMBL2157605
CHEMBL580441
cd-3
4-amino-3-methyl-n-(beta-methanesulfonamidoethyl)-n-ethylaniline
DTXSID4043779
4-(n-ethyl-n-2-methanesulfonylaminoethyl)-2-methylphenylenediamine
n-(2-((4-amino-3-methylphenyl)(ethyl)amino)ethyl)methanesulfonamide
4-amino-3-methyl-n-ethyl-n-(.beta.-(methanesulfonamido)ethyl)aniline
3-methyl-4-amino-n,n-(ethyl-.beta.-mesylaminoethyl)-aniline
4-amino-n-ethyl-n-(.beta.-methanesulfonamidoethyl)-m-toluidine
4-amino-3-methyl-n-ethyl-n-(.beta.-methylsulfonamidoethyl)aniline
4-amino-3-methyl-n-ethyl-n-(2-methanesulfonamidoethyl)aniline
n-[2-[(4-amino-m-tolyl)ethylamino]ethyl]methanesulphonamide
BCP10485
Q27265600
STARBLD0000853
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (50.00)18.7374
1990's4 (28.57)18.2507
2000's1 (7.14)29.6817
2010's1 (7.14)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.45 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies4 (25.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
toluene
methylbenzene : Any alkylbenzene that is benzene substituted with one or more methyl groups.		3.3770methylbenzene;
toluenes;
volatile organic compound		cholinergic antagonist;
fuel additive;
neurotoxin;
non-polar solvent
anthralin
Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.. anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.		1.9710anthracenesantipsoriatic
dimaprit
Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.		2.3720imidothiocarbamic ester
n-methyl-4-aminophenol
4-methylaminophenol : The phenol that is the N-methyl derivative of 4-aminophenol.		2.3720phenolsallergen
n,n-diethyl 4-phenylenediamine
N,N-diethyl 4-phenylenediamine: RN given refers to parent cpd		1.9610
n-isopropyl-n-phenyl-4-phenylenediamine
N-isopropyl-N-phenyl-4-phenylenediamine: RN given refers to parent cpd; structure in sixth source		1.9610
isothiuronium
Isothiuronium: An undecenyl THIOUREA which may have topical anti-inflammatory activity.		2.3720
butantrone
[no description available]		1.9710
3-methyl-n,n-diethyl-p-phenylenediamine
3-methyl-N,N-diethyl-p-phenylenediamine: RN given refers to parent cpd; structure		3.5890
4-amino-n-ethyl-n-(beta-hydroxy-ethyl)-m-toluidine
4-amino-N-ethyl-N-(beta-hydroxy-ethyl)-m-toluidine: causes allergic contact dermatitis		3.3770
nordimaprit
nordimaprit: effective agonist in the inhibition of lymphocyte activation		2.3720
ConditionIndicatedRelationship StrengthStudiesTrials
Plasmodium falciparum Malaria
[description not available]		02.110
Malaria, Falciparum
Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.		02.110
Licheniform Eruptions
[description not available]		02.3820
Lichen Ruber Planus
[description not available]		02.8840
Dermatitis, Occupational
A recurrent contact dermatitis caused by substances found in the work place.		03.0750
Lichen Planus
An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a saw-tooth pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.		02.8840
Contact Dermatitis
[description not available]		03.0650
Dermatitis, Contact
A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.		03.0650
Eczema, Atopic
[description not available]		01.9610
Diseases, Occupational
[description not available]		02.3720
Dermatitis, Atopic
A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.		01.9610
Allergic Contact Dermatitis
[description not available]		02.6830
Hand Dermatosis
[description not available]		02.3920
Hand Dermatoses
Skin diseases involving the HANDS.		02.3920
Dermatitis, Allergic Contact
A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.		02.6830
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)		0210
Anasarca
[description not available]		01.9710
Edema
Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.		01.9710
Erythema
Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.		01.9710